 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/5 mg comp.x 28 | $65.289,14 | (20/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 160/12.5/10 mg comp.x 28 | $64.667,97 | (20/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.333,99 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $65.289,14 | (20/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $65.289,14 | (20/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.644,57 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $69.046,92 | (20/05/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $34.523,46 |
|
|
|
|
| |
